Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center, explains how older patients with glaucoma may lose nerve fiber layer at a quicker rate than younger patients.
The search for safer surgical options for our older patients remains an unment need in glaucoma care, said Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center.
Transcript
What are the next steps for understanding and implementing the best medical and surgical practices or managment patterns for older patients with glaucome?
I think the next step is ongoing research to find safer alternatives, and in many cases safer surgical alternatives than traditional surgeries such as trabeculectomy and glaucoma drainage device procedures, which are rife with more complications. There's a whole class of surgeries called MIGS, minimally invasive glaucoma surgeries, that are directed in lowering patients' eye pressure, with fewer complications. There are lots of different MIGS options, but there's still not one out there that can lower the patient's pressure as low as a standard trabeculectomy can. So I think the search for safer surgical options for our elderly patients is an area that has this unmet need for our practices.
Do you have any closing thoughts you'd like to share?
Based on some of the work out of Duke, when you look at an older population glaucoma patient vs a younger population, we find that older patients may lose nerve fiber layer at a quicker rate than their younger counterparts. So we may need to rethink our process of being less aggressive in an older patient and really pay attention to how their visual fields are progressing in a nerve fiber layer analysis and present what're the surgical options that patients need to have that.
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen